T. David Koster

Apr 18, 2024 | resmedjournal.com | T. David Koster |Pallav L. Shah |Arschang Valipour |Klinik Floridsdorf |Gerard J. Criner |Felix J.F. Herth | +9 more

Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study. Am J Respir Crit Care Med. 2016; 194: 1073-1082Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. N Engl J Med. 2015; 373: 2325-2335A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM). Am J Respir Crit Care Med.

Jul 1, 2023 | openres.ersjournals.com | T. David Koster |Karin Klooster

DiscussionWe found that despite a technically optimal procedure, nonresponders to EBV treatment are characterised by a less ideal or non-ideal target lobe: less emphysematous destruction, a more homogeneous distribution of both emphysema destruction and perfusion, less air trapping and more preserved perfusion. Baseline disease severity characteristics, such as the amount of hyperinflation or level of exercise capacity, were not indicators of response.